“It is those who attempt the impossible who create the possible.”
Lisa Götz, Director Operations
OUR EXPERTISE
SCOPE International has forged long-term relationships with well-known companies in the pharmaceutical, biotech, biosimilars, medical device, diagnostics, generics and functional food sectors, and has gained considerable experience in conducting phase IIa – IV clinical studies, non-interventional studies and post-marketing surveillance.
We have the benefit of established ties with renowned life-science companies, universities and hospitals, as well as long-term personal contacts with a wide range of clinical sites and patient advocacy groups. Thanks to our professionalism, we are highly regarded amongst investigators and sponsors for our experienced monitoring teams and proactive project and site management.
YOUR PARTNER FOR ALL AREAS
OF CLINICAL DEVELOPMENT
OUR RANGE OF EXPERTISE
Whatever your project, SCOPE’s team of expert staff specialize in providing a complete service that is tailored to your needs – whether it’s a clinical trial, post-authorization study, rescue study, or even a complex device or diagnostic combination or adaptive trial. We have the experience, know-how, and resources to guide you smoothly through all development phases. In business since 2000, SCOPE has conducted over 300 studies with 87,000 patients worldwide. We have offices in 30 countries across Europe, Russia, Ukraine, and the U.S. with 250 permanent employees – and with our partner network, we are operational across all continents and markets wherever patient populations are located.